Click on the links below to preview selected pages from this course.
- Myeloproliferative Neoplasms
- Chronic Myeloid Leukemia
- Chronic Myeloid Leukemia (CML)
- CML and the Philadelphia Chromosome
- Laboratory Investigation of CML
- CML Peripheral Blood Smear
- Progression of CML
- Treatment of CML
- The Philadelphia chromosome, associated with chronic myeloid leukemia (CML), involves a reciprocal translocation of genes from which two chromosomes?
- Chronic Neutrophilic Leukemia
- Hypereosinophilic Syndrome/Chronic Eosinophilic Leukemia
- Hypereosinophilic Syndrome (HES)
- Chronic Eosinophilic Leukemia (CEL)
- What causes the characteristic heart and/or lung damage frequently demonstrated in patients with chronic eosinophilic leukemia?
- Essential Thrombocythemia
- Essential Thrombocythemia (ET)
- Diagnosis of Essential Thrombocythemia (ET)
- Diagnosis of Essential Thrombocytosis (ET): Bone Marrow Findings
- Essential Thrombocytosis (ET) Diagnosis
- ET Treatment
- Which of the following thrombocytic characteristics are often associated with essential thrombocytosis (ET)?
- Primary Myelofibrosis
- Primary Myelofibrosis (PMF)
- Diagnosis of Primary Myelofibrosis (PMF)
- Diagnosis of Primary Myelofibrosis: World Health Organization (WHO) Criteria
- Which of the following red blood cell morphologic features is associated with primary myelofibrosis?
- Polycythemia Vera
- Myeloproliferative Neoplasm, Unclassifiable (MPN-u)
- Myeloproliferative Neoplasms, Unclassifiable (MPD-u)
- Table: Laboratory Findings Associated with Myeloproliferative Neoplasms (MPNs)
Level of instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for medical laboratory science students and pathology residents.
Author information: Leah Coppolino, MPH, CLS(NCA), MT(ASCP) is the Director of Education and Outreach in the Department of Pathology and Laboratory Medicine at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania. She holds a Masters in Public Health from Thomas Jefferson University.
Reviewer information: Rebecca J. Laudicina, PhD, MLS(ASCP)CM is Professor Emeritus in the Division of Clinical Laboratory Science at The University of North Carolina at Chapel Hill’s School of Medicine. She obtained a Master of Education and PhD in Educational Psychology from Temple University. She is the author of numerous hematology-related publications.